标题
New and emerging medical therapies in Parkinson’s disease
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 17, Issue 7, Pages 895-909
出版商
Informa Healthcare
发表日期
2016-02-02
DOI
10.1517/14656566.2016.1149163
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial
- (2015) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study
- (2015) Per Svenningsson et al. BRAIN
- A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease
- (2015) Tomoyoshi Kondo et al. CLINICAL NEUROPHARMACOLOGY
- Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial
- (2015) Cheryl H. Waters et al. CNS DRUGS
- Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease
- (2015) J. J. Ferreira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Apomorphine hydrochloride for the treatment of Parkinson’s disease
- (2015) Elisa Unti et al. Expert Review of Neurotherapeutics
- Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease
- (2015) Karl Kieburtz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epigenetic mechanisms in Parkinson's disease
- (2015) Ya Feng et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Transcutaneous Tibial Nerve Stimulation in the Treatment of Lower Urinary Tract Symptoms and Its Impact on Health-Related Quality of Life in Patients With Parkinson Disease
- (2015) Maria Carolina Perissinotto et al. Journal of Wound Ostomy and Continence Nursing
- Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
- (2015) Benjamin Dehay et al. LANCET NEUROLOGY
- Gastrointestinal dysfunction in Parkinson's disease
- (2015) Alfonso Fasano et al. LANCET NEUROLOGY
- Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
- (2015) LANCET NEUROLOGY
- Advances in functional neurosurgery for Parkinson's disease
- (2015) Leo Verhagen Metman et al. MOVEMENT DISORDERS
- Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study
- (2015) Miho Murata et al. MOVEMENT DISORDERS
- New treatments for levodopa-induced motor complications
- (2015) Olivier Rascol et al. MOVEMENT DISORDERS
- Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease
- (2015) Leo Verhagen Metman et al. MOVEMENT DISORDERS
- Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
- (2015) Rajesh Pahwa et al. MOVEMENT DISORDERS
- Cell-based therapies for Parkinson disease—past insights and future potential
- (2015) Roger A. Barker et al. Nature Reviews Neurology
- Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease
- (2015) D. Calandrella et al. NEUROLOGY
- Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry
- (2015) Maríateresa Buongiorno et al. PARKINSONISM & RELATED DISORDERS
- Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease
- (2015) Theresa A. Zesiewicz et al. PARKINSONISM & RELATED DISORDERS
- Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease
- (2015) Chun-Hyung Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Apomorphine hydrochloride for the treatment of Parkinson’s disease
- (2015) Elisa Unti et al. Expert Review of Neurotherapeutics
- A Nurr1 Agonist Causes Neuroprotection in a Parkinson’s Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C)
- (2015) Gaynor A. Smith et al. PLoS One
- Adenosine A2A Receptor Antagonists in Parkinson’s Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued
- (2014) Annalisa Pinna CNS DRUGS
- Therapeutic potential of targeting glutamate receptors in Parkinson’s disease
- (2014) Clare Finlay et al. JOURNAL OF NEURAL TRANSMISSION
- Adenosine 2A Receptor Occupancy by Tozadenant and Preladenant in Rhesus Monkeys
- (2014) O. Barret et al. JOURNAL OF NUCLEAR MEDICINE
- Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
- (2014) Robert A Hauser et al. LANCET NEUROLOGY
- The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model
- (2014) Erwan Bezard et al. MOVEMENT DISORDERS
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Droxidopa for the Short-Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)
- (2014) Robert A. Hauser et al. MOVEMENT DISORDERS
- Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results
- (2014) Hubert H. Fernandez et al. MOVEMENT DISORDERS
- Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics
- (2014) Peter A. LeWitt MOVEMENT DISORDERS
- Adenosine A2A receptor antagonist istradefylline 20 versus 40 mg/day as augmentation for Parkinson’s disease: a meta-analysis
- (2014) Chuan Zhu et al. NEUROLOGICAL RESEARCH
- Droxidopa for neurogenic orthostatic hypotension: A randomized, placebo-controlled, phase 3 trial
- (2014) H. Kaufmann et al. NEUROLOGY
- Deep-Brain Stimulation — Entering the Era of Human Neural-Network Modulation
- (2014) Michael S. Okun NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients
- (2014) Fabrizio Stocchi et al. PARKINSONISM & RELATED DISORDERS
- Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease
- (2014) Christopher Kobylecki et al. PARKINSONISM & RELATED DISORDERS
- Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease
- (2014) Michael A. Schwarzschild et al. JAMA Neurology
- Parkinson Disease Subtypes
- (2014) Mary Ann Thenganatt et al. JAMA Neurology
- A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
- (2014) et al. JAMA Neurology
- Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates
- (2014) Nicolas Morin et al. Frontiers in Neurology
- Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil
- (2013) Stéphane Thobois et al. BRAIN
- Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial
- (2013) D. Devos et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
- (2013) Jeffrey Cummings et al. LANCET
- Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
- (2013) Robert A Hauser et al. LANCET NEUROLOGY
- Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
- (2013) Anthony HV Schapira et al. LANCET NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- Adenosine A2Areceptor antagonist istradefylline reduces daily OFF time in Parkinson's disease
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study
- (2013) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD)
- (2013) MOVEMENT DISORDERS
- Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia
- (2013) Erwan Bezard et al. MOVEMENT DISORDERS
- Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
- (2013) Amaal AlDakheel et al. Neurotherapeutics
- Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease
- (2013) Rajesh Pahwa et al. PARKINSONISM & RELATED DISORDERS
- Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson's disease (EDAP): Table 1
- (2013) Hideyuki Sawada et al. BMJ Open
- Pharmacokinetics of Levodopa/Carbidopa Microtablets Versus Levodopa/Benserazide and Levodopa/Carbidopa in Healthy Volunteers
- (2012) Dag Nyholm et al. CLINICAL NEUROPHARMACOLOGY
- Actively Transported Levodopa Prodrug XP21279
- (2012) Peter A. LeWitt et al. CLINICAL NEUROPHARMACOLOGY
- Pharmacokinetics and Pharmacodynamics of Gastroretentive Delivery of Levodopa/Carbidopa in Patients With Parkinson Disease
- (2012) Cuiping Chen et al. CLINICAL NEUROPHARMACOLOGY
- Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
- (2012) M. A. Cenci et al. CNS & Neurological Disorders-Drug Targets
- Emerging therapies for Parkinsonʼs disease
- (2012) Werner Poewe et al. CURRENT OPINION IN NEUROLOGY
- Therapies in Parkinsonʼs disease
- (2012) Joseph Jankovic et al. CURRENT OPINION IN NEUROLOGY
- Long-term duodenal levodopa infusion in Parkinson’s disease: a 3-year motor and cognitive follow-up study
- (2012) Maurizio Zibetti et al. JOURNAL OF NEUROLOGY
- A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients
- (2012) Jay S. Schneider et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study)
- (2012) P. A. LeWitt et al. NEUROLOGY
- -Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons
- (2012) M. Decressac et al. Science Translational Medicine
- Preclinical Biomarkers of Parkinson Disease
- (2011) Yuncheng Wu et al. ARCHIVES OF NEUROLOGY
- A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients
- (2011) Santiago Perez Lloret et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
- (2011) Robert A Hauser et al. LANCET NEUROLOGY
- AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials
- (2011) Daniela Berg et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease
- (2011) A. F. Ramlackhansingh et al. NEUROLOGY
- Istradefylline for Parkinson's disease patients experiencing motor fluctuations: Results of the KW-6002-US-018 study
- (2011) Emmanuelle Pourcher et al. PARKINSONISM & RELATED DISORDERS
- Efficacy of zonisamide in a case of Parkinson’s disease with intractable resting and re-emergent tremor
- (2010) M. Iijima et al. EUROPEAN JOURNAL OF NEUROLOGY
- Quantification of Indirect Pathway Inhibition by the Adenosine A2a Antagonist SYN115 in Parkinson Disease
- (2010) K. J. Black et al. JOURNAL OF NEUROSCIENCE
- Reduction of L-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
- (2010) T. H. Johnston et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Abstracts of The Movement Disorder Society's Thirteenth International Congress of Parkinson's Disease and Movement Disorders
- (2010) MOVEMENT DISORDERS
- The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates
- (2010) Tom H. Johnston et al. MOVEMENT DISORDERS
- A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys
- (2010) Daniella Rylander et al. NEUROBIOLOGY OF DISEASE
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death
- (2009) Kaoru Saijo et al. CELL
- Development of swelling/floating gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for Losartan and its clinical relevance in healthy volunteers with CYP2C9 polymorphism
- (2009) Ray-Neng Chen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Metabotropic glutamate receptor type 5 in levodopa-induced motor complications
- (2009) Bazoumana Ouattara et al. NEUROBIOLOGY OF AGING
- Adenosine A2Areceptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)
- (2008) Peter A. LeWitt et al. ANNALS OF NEUROLOGY
- Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
- Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
- (2008) Pedro J. García Ruiz et al. MOVEMENT DISORDERS
- A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease
- (2008) M. Stacy et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now